Cargando…
Indoleamine 2,3-Dioxygenase 1 Inhibitor-Loaded Nanosheets Enhance CAR-T Cell Function in Esophageal Squamous Cell Carcinoma
In chimeric antigen receptor (CAR)-T cell therapy, the role and mechanism of indoleamine 2, 3 dioxygenase 1 (IDO1) in enhancing antitumor immunity require further study. IDO1 is one of the most important immunosuppressive proteins in esophageal squamous cell carcinoma (ESCC). However, the IDO1 inhib...
Autores principales: | Shao, Jingwen, Hou, Lin, Liu, Jinyan, Liu, Yulin, Ning, Jie, Zhao, Qitai, Zhang, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019778/ https://www.ncbi.nlm.nih.gov/pubmed/33828565 http://dx.doi.org/10.3389/fimmu.2021.661357 |
Ejemplares similares
-
Involvement of Indoleamine 2,3-Dioxygenase in Impairing Tumor-Infiltrating CD8(+) T-Cell Functions in Esophageal Squamous Cell Carcinoma
por: Zhang, Ge, et al.
Publicado: (2011) -
Localization of Indoleamine 2,3-Dioxygenase-1 and Indoleamine 2,3-Dioxygenase-2 at the Human Maternal-Fetal Interface
por: Kudo, Yoshiki, et al.
Publicado: (2020) -
Indoleamine 2,3-dioxygenase 1 and overall survival of patients diagnosed with esophageal cancer
por: Rosenberg, Ari J., et al.
Publicado: (2018) -
Indoleamine 2,3-Dioxygenase (IDO) Expression Is an Independent Prognostic Marker in Esophageal Adenocarcinoma
por: Loeser, Heike, et al.
Publicado: (2020) -
Editorial: Targeting Indoleamine 2,3-dioxygenases and Tryptophan Dioxygenase for Cancer Immunotherapy
por: Brochez, Lieve, et al.
Publicado: (2021)